<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945824</url>
  </required_header>
  <id_info>
    <org_study_id>OTX-DPI-2020-401</org_study_id>
    <nct_id>NCT04945824</nct_id>
  </id_info>
  <brief_title>A Human Factors Study to Evaluate a Novel Intracanalicular Insertion Device in Healthy Subjects</brief_title>
  <official_title>An Open-label, Multi-center, Bilateral, Human Factors Study to Evaluate the Utilization and Safety of a Novel Intracanalicular Insertion Device in Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ocular Therapeutix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ocular Therapeutix, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, multi-center, bilateral, human factors study designed to evaluate the&#xD;
      utilization and safety of a novel intracanalicular insertion device in healthy subjects and&#xD;
      to evaluate the concentration of DEXTENZA in tears. Each subject's participation is expected&#xD;
      to last for approximately 1 month from the DEXTENZA insertion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ease of insertion as assessed by Post-Insertion Investigator Questionnaire</measure>
    <time_frame>Assessed at Visit 1 (Day 1)</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Novel Intracanalicular Insertion Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Ophthalmic</intervention_name>
    <description>Insertion Device: A handheld mechanical device used by the clinician to dilate the punctum and deliver the DEXTENZA insert into the canaliculus; designed to be single-use and pre-loaded with a single DEXTENZA insert.</description>
    <arm_group_label>Novel Intracanalicular Insertion Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilator</intervention_name>
    <description>Intracanalicular Dilator Device</description>
    <arm_group_label>Novel Intracanalicular Insertion Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Are a healthy adult subject aged 18 years or older with no known significant health&#xD;
             problems&#xD;
&#xD;
          -  Are willing to refrain from wearing contact lens for the duration of the study&#xD;
&#xD;
          -  Are willing and able to comply with clinic visits and study related procedures&#xD;
&#xD;
          -  Are willing and able to sign the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have known significant health problems&#xD;
&#xD;
          -  Are women of reproductive potential&#xD;
&#xD;
          -  Are breastfeeding&#xD;
&#xD;
          -  Are a known steroid responder&#xD;
&#xD;
          -  Have a history of herpes simplex virus keratitis or present active bacterial, viral,&#xD;
             or fungal keratitis in either eye&#xD;
&#xD;
          -  Have a history of complete punctal occlusion in one or both punctum&#xD;
&#xD;
          -  Currently use topical ophthalmic steroid medications&#xD;
&#xD;
          -  Are unwilling or unable to comply with the study protocol&#xD;
&#xD;
          -  Are determined by the Investigator to not be included for reasons not already&#xD;
             specified (e.g., systemic, behavioral, or other ocular&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clinical Project Manager</last_name>
    <phone>781-357-4000</phone>
    <email>clinicalaffairs@ocutx.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ocular Therapeutix, Inc.</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clinical Project Manager</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

